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Abstract Amyloid fibril formation and deposition are the basis 
for a wide range of diseases, including spongiform encephalo-
pathies, Alzheimer's and familial amyloidotic polyneuropathies. 
However, the molecular mechanisms of amyloid formation are 
still poorly characterised. In certain forms of familial amyloido-
tic polyneuropathy (FAP), the amyloid fibrils are mostly 
constituted by variants of transthyretin (TTR). V30M-TTR is 
the most frequent variant, and L55P-TTR is the variant 
associated with the most aggressive form of amyloidosis. Here, 
we report gel filtration chromatography experiments to char-
acterise the aggregation states of WT-, V30M-, L55P-TTR and 
a non-amyloidogenic variant, T119M-TTR, in solution, at nearly 
physiological pH. These studies show that all four protein 
tetramers dissociate to monomer upon dilution, in the sub-
micromolar range, at pH 7.0. The amyloidogenic proteins 
V30M- and L55P-TTR show a complex equilibrium between 
monomers, tetramers and high molecular weight aggregate 
species. These aggregates dissociate directly to monomer upon 
dilution. This study shows that the tendency to form aggregates 
among the four studied proteins correlates with their known 
amyloidogenic potential. Thus, the amyloidogenic mutations 
could perturb the structure and/or stability of the monomeric 
species leading initially to the formation of soluble aggregates 
and at a later stage to insoluble amyloid fibrils. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Transthyretin (TTR) is a homo-tetrameric protein with a 
total molecular weight of 55 kDa and 127 amino acid residues 
per subunit, found in the cerebrospinal fluid and in the plas-
ma. TTR transports thyroxine and retinol in association with 
the retinol-binding protein. In certain forms of familial amy-
loidotic polyneuropathy (FAP), characterised by early impair-
ment of temperature and pain sensation in the feet, and evolv-
ing to autonomic dysfunction with generalised amyloidosis [1], 
the amyloid fibrils are mostly constituted by variants of TTR 
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Abbreviations: TTR, transthyretin; V30M-TTR, transthyretin with 
valine at position 30 replaced by a methionine; L55P-TTR, transthyr-
etin with leucine at position 55 replaced by a proline; T119M-TTR, 
transthyretin with threonine at position 119 replaced by a methionine; 
WT, wild type; Tris, tris(hydroxymethyl)aminomethane 
[2]. Among these variants, V30M-TTR is the most frequent 
[2], and L55P-TTR is the variant associated with the most 
aggressive form of amyloidosis, characterised by an early 
age of onset, between 15 and 20 years old [3]. T119M-TTR 
was originally described in a kindred without amyloidosis [4] 
and has now been found frequently in several populations, 
including the Portuguese population [5]. This variant is non-
amyloidogenic and it is thought to protect against FAP indi-
viduals who also carry the V30M mutation [6]. Recent studies 
have suggested that acid-induced partial denaturation of TTR 
is sufficient to effect amyloid fibril formation by self-assembly 
of a denaturation intermediate [7,8], and that T119M-TTR is 
more stable toward acid-induced fibril formation than WT-
TTR, in contrast with V30M-TTR which is less stable [9]. 
Comparison between the crystal structures of WT- and 
V30M-TTR showed a very similar global fold for both pro-
teins with the tetramer having a central cylindrical cavity 
where thyroxine binds. Each monomer of TTR is a flattened 
|3-barrel with residue 30 in the interior. Substitution of valine 
30 by methionine forces the (3-sheets of the monomer approx-
imately 1 A apart, resulting in the distortion of the thyroxine-
binding cavity [10,11]. However, the small differences between 
the crystal structures of WT- and V30M-TTR have not clearly 
pointed out the causes for the amyloidogenicity of V30M-
TTR. Preliminary X-ray diffraction studies [12] of L55P-
TTR showed that the asymmetric unit contains eight mono-
mers instead of two monomers as in the WT- and V30M-TTR 
asymmetric units. 
In order to evaluate the aggregation states of WT-, V30M-, 
L55P- and T119M-TTR, in solution, we have carried out a 
comparative study by gel filtration chromatography [13,14]. 
This study showed that, at approximately physiological pH, 
WT- and T119M-TTR have a very low tendency to form 
aggregates, and V30M-TTR and L55P-TTR have a high 
and a very high tendency to form aggregates, respectively. 
These different tendencies to form soluble aggregates correlate 
with the amyloidogenic potential of each one of the four var-
iants studied. 
2. Materials and methods 
Recombinant WT-, V30M-, L55P- and T119M-TTR were produced 
in an Escherichia coli expression system [15] and purified as described 
previously [16]. To date, structural [10,11] and functional studies [16] 
have not shown any significant differences between TTR from human 
plasma and recombinant sources. All the TTR samples for gel filtra-
tion chromatography were diluted more than 10 times in gel filtration 
chromatography buffer, 20 mM sodium phosphate buffer, 150 mM 
sodium chloride, pH 7.0. Protein concentrations were determined 
spectrophotometrically, at 280 nm, using an extinction coefficient of 
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7.76 X 104 M 1 cm 1 based on a 55 kDa molecular weight for TTR 
0428o(l%)=14.1 mg-
1 ml cm"1) [17]. 
Gel filtration chromatography was performed on a Pharmacia 
FPLC Superdex-75 HR column, coupled to a Pharmacia high preci-
sion pump P-500 and a UV detector, equipped with a deuterium lamp, 
and an integrator from Konik Instruments. The column was allowed 
to equilibrate with 2-5 column volumes with chromatography buffer, 
and was frequently cleaned with 0.5 M NaOH, and always before a 
new TTR variant was injected. Different concentrations of transthyr-
etin variants, each in 100 ul, were injected using a 100 ul loop. Final 
runs were performed at a flow rate of 0.4 ml/min. Apparent molecular 
weights were calculated by interpolation on a elution volume versus 
log(molecular weight) calibration curve for four protein standards: 
bovine serum albumin (66 kDa), carbonic anhydrase (29 kDa), cyto-
chrome c (12.4 kDa) and aprotinin (6.5 kDa). 
All chemicals were of the highest purity commercially available and 
were purchased from Sigma Chemical Company. 
3. Results 
Several concentrations of wild type and mutant transthyr-
etins were prepared in chromatography buffer from an initial 
pure concentrated batch in 10 mM Tris-glycine, pH 8.8. Final 
dilutions were allowed to incubate at room temperature for 
24-48 h before being applied to the gel filtration chromatog-
raphy column. Fig. 1 shows the gel filtration elution profiles 
of WT-, V30M-, L55P- and T119M-TTR, at pH 7.0, at high 
( ~ 3 uM) and low concentration (~0.3 |iM). Peaks corre-
sponding to different molecular species in solution are ob-
served with apparent molecular weights in the order of 60 
kDa for the tetramer (elution volume = 8.8 ml), 5.9 kDa for 
the monomer (elution volume =15.2 ml), and aggregates of 
molecular weight higher than 70 kDa, the resolving limit of 
the column. For 3 uM WT-TTR (Fig. 1A), most of the pro-
tein is in the tetrameric form. Dilution to 0.3 uM (Fig. 1A) 
leads to dissociation of a significant amount of the tetramer to 
monomer. A similar behaviour is observed for T119M-TTR 
(Fig. ID), however a slightly higher ratio of tetramer to 
monomer is observed at 0.3 |J.M (Fig. ID). In the case of 
V30M-TTR, at 3 uM (Fig. IB) most of the protein is in the 
tetrameric form, but significant amounts of high molecular 
weight aggregates are observed. Upon dilution to 0.3 |iM 
these aggregates are not observed and a mixture of tetramer 
and monomer is obtained (Fig. IB). For L55P-TTR, at 1.5 
|j.M (Fig. 1C) a similar amount of aggregate and tetramer is 
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Fig. 1. Gel filtration chromatograms of WT-TTR (A), V30M-TTR (B), L55P-TTR (C) and T119M-TTR (D). Applied protein concentrations 
are indicated. Before being applied to the column, samples were allowed to equilibrate at room temperature and at their final concentrations, 
for at least 24 h. All chromatograms were run at a flow rate of 0.4 ml/min. 
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Fig. 2. Percentage of TTR molecular species in solution as a function of protein concentration, at pH 7, from gel filtration chromatography: 
(A) WT-TTR, (B) V30M-TTR, (C) L55P-TTR and (D) T119M-TTR. 
observed. At 0.3 u,M, three large peaks are observed corre-
sponding to aggregate, tetramer and monomer. This behav-
iour for all four proteins is highly reproducible as long as the 
solution conditions are maintained. The chromatograms are 
also indicative of slow equilibrium between the different mo-
lecular species. In fact, short incubation times after dilution 
produce chromatographic profiles more characteristic of the 
initial conditions. Thus, for all chromatograms shown we 
waited until equilibrium was reached before injecting the sam-
ples in the gel filtration chromatography system. 
To characterise in more detail the equilibria in solution for 
all four proteins, we ran gel filtration experiments at up to 
eight different protein concentrations varying between 0.1 and 
10 (J.M. Fig. 2 shows that, for all proteins, dilution leads to 
dissociation of the tetramer to monomer, with a decrease in 
the amount of tetramer corresponding to an increase in the 
amount of monomer. However, in the case of V30M-TTR 
(Fig. 2B) and L55P-TTR (Fig. 2C), two amyloidogenic var-
iants, a significant amount of aggregate species is also ob-
served. In L55P-TTR, the protein that produces the most 
aggressive form of amyloidosis, the aggregate species are ob-
served for a wide range of protein concentrations, and in 
much higher amounts than in the case of V30M-TTR (Fig. 
2B,C). There is no evidence for any significant amount of 
aggregate species in WT- or T119M-TTR, in the protein con-
centration range studied (Fig. 2A,D). Additionally, it seems 
that the T119M-TTR tetramer is slightly more stable to dis-
sociation than the other three proteins. 
In order to probe the nature of the aggregate species in 
V30M- and L55P-TTR we collected and reinjected, at several 
different incubation times and at two different protein concen-
trations, the aggregate peaks. Fig. 3 (A, B and C) shows a 
time course for the dissociation of the aggregate to monomer 
in V30M-TTR, at low initial protein concentration (~0.03 
HM). Two main peaks are observed for elution volumes of 
7.7 ml and 15.2 ml, corresponding to the initial aggregate 
and monomer, respectively. Two main peaks, at exactly the 
same elution volumes, are also observed at higher initial pro-
tein concentration (~0.18 p,M) (Fig. 3D). In both cases, no 
tetramer was observed. Determining the dissociation equili-
brium from tetramer to monomeric species is very slow, and 
since even at early time points (Fig. 3A) no tetramer is ob-
served, we conclude that the aggregate apparently dissociates 
directly to monomer. 
4. Discussion 
Gel filtration chromatography experiments with WT-TTR 
show that the native tetrameric form dissociates to monomer 
upon dilution, in the sub-micromolar range. There is no evi-
dence for aggregates at pH 7 and at sub-micromolar protein 
concentrations. T119M-TTR tetramer also dissociates to 
monomer upon dilution, but apparently at a slightly lower 
protein concentration, indicating a slightly higher stability to 
dissociation in this variant. The tetrameric form of the amy-
loidogenic variant V30M-TTR dissociates to monomer with 
traces of dimer present. In this amyloidogenic variant a sig-
nificant amount of aggregates with molecular weights higher 
than 70 kDa is observed, in the low micromolar concentration 
range. Apparently, these aggregates are in a slow equilibrium 
with the monomeric form of the protein, as we have shown by 
collecting and reinjecting the aggregates. In L55P-TTR, the 
presence of aggregate species is even more prevalent than in 
V30M-TTR. For this variant the tetramer also dissociates to 
monomer in the sub-micromolar range, but there is a large 
amount of aggregates in equilibrium, in solution, over a wide 
range of concentrations. This agrees with the preliminary X-
ray data showing eight monomers instead of two monomers 
in the asymmetric unit [12]. 
To date, most of the mechanisms proposed for amyloid 
fibril formation by TTR are based on the assumption that 
the protein has to be in contact with a low pH medium which 
induces tetramer dissociation [7] and partial monomer unfold-
ing [8]. Our results indicate that, even at pH 7.0, tetramer 
dissociation for the four proteins occurs around a similar, 
but not identical, sub-micromolar concentration range, with 
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Fig. 3. Time course of V30M-TTR aggregate dissociation, at pH 
7.0, followed by gel filtration chromatography. The sample, at a 
low initial protein concentration (~0.03 uM), was applied to the 
column (A) 2 h, (B) 24 h and (C) 48 h after the aggregate had been 
collected from the initial chromatography. A second gel filtration 
chromatography experiment was performed at a higher initial pro-
tein concentration (~0.18 uM) and the sample was applied to the 
column 24 h after the aggregate had been collected from the initial 
chromatography (D). 
apparently a slightly higher tetramer stability to dissociation 
in T119M-TTR. However, the tendency for aggregate forma-
tion is significantly different in the four proteins: L55P-
T T R » V 3 0 M - T T R » W T - T T R > T 1 1 9 M - T T R . This de-
creasing tendency for aggregate formation among the four 
proteins correlates with their decreasing amyloidogenic poten-
tial. In fact, L55P-TTR produces the most aggressive forms of 
FAP, followed by V30M-TTR. W T - T T R does not produce 
FAP, but it is responsible for an amyloidosis with a late onset 
- senile systemic amyloidosis. T119M-TTR is particularly in-
teresting from a clinical point of view because subjects carry-
ing genes for V30M-TTR and T119M-TTR do not develop 
F A P , which would indicate an almost 'anti-amyloidogenic' 
function of T119M-TTR. This could be explained by the for-
mation of mixed V30M/T119M-TTR tetramer proteins with a 
slightly higher stability to dissociation and a decreased ten-
dency for aggregate formation due to the presence of T119M-
T T R subunits. In fact, our results seem to indicate a higher 
stability to dissociation of the T119M-TTR variant. This is 
also corroborated by recent results by Alves et al. [18] who 
compared different serum mutan t TTRs on their resistance to 
dissociation into monomers by 4 M urea isoelectric focusing. 
A higher tetrameric stability of T T R was found in heterozy-
gotic carriers of the T119M variant in contrast to a lower 
resistance to urea dissociation found for V30M heterozygotic 
carriers. Compound heterozygotes for the two variants pre-
sented a pat tern similar to the normal individuals [18]. 
In conclusion, it seems that, even at physiological p H , tet-
ramer stability to dissociation could play some role in the 
amyloidogenic potential of TTR, but more importantly the 
structure and/or dynamics of the monomeric species seem to 
play crucial role in aggregate formation and potentially amy-
loidosis. Some of the T T R mutat ions could perturb the struc-
ture and/or stability of the monomeric species to an extent 
that could lead initially to the formation of soluble aggregates 
and at a later stage to insoluble amyloid fibrils. 
Acknowledgements: This work was supported in part by a grant from 
PRAXIS XXI (PRAXIS/2/2.1/SAU/1287/95). We thank Mr. Paul 
Moreira for technical assistance in preparing recombinant transthyr-
etin. 
References 
[1 
[2: 
[3: 
[4 
[5: 
[e: 
[?: 
[iff 
[ii 
[12! 
[13! 
[14! 
[15! 
[16! 
[17! 
[18! 
Andrade, C. (1952) Brain 75, 408-427. 
Saraiva, M.J.M. (1996) J. Periph. Nerv. Syst. 1, 179-188. 
Jacobson, D.R., McFarlin, D.E., Kane, I. and Buxbaum, J.N. 
(1992) Hum. Genet. 89, 353-356. 
Harrison, H.H., Gordon, G.D., Nichols, W.C. and Benson, 
M.D. (1991) Am. J. Med. Genet. 39, 442-452. 
Alves, I.L., Altland, K., Almeida, M.R., Winter, P. and Saraiva, 
M.J.M. (1997) Hum. Mutat. 9, 226-233. 
Coelho, T., Chorao, R., Sousa, A., Alves, I., Torres, M.F. and 
Saraiva, M.J.M. (1996) Neuromusc. Disord. 6, 27-32. 
Colon, W. and Kelly, J.W. (1992) Biochemistry 31, 8654-8660. 
McCutchen, S.L., Lai, Z., Miroy, G.J., Kelly, J.W. and Colon, 
W. (1995) Biochemistry 34, 13527-13536. 
Bonifacio, M.J., Sakaki, Y. and Saraiva, M.J.M. (1996) Biochim. 
Biophys. Acta 1365, 35^12. 
Terry, C.J., Damas, A.M., Oliveira, P., Saraiva, M.J.M., Alves, 
I.L., Costa, P.P., Matias, P.M., Sakaki, Y. and Blake, C.C.F. 
(1993) EMBO J. 12, 735-741. 
Hamilton, J.A., Steinrauf, L.K., Braden, B.C., Liepnieks, J., Ben-
son, M.D., Holmgren, G., Sandgren, O. and Steen, L. (1993) 
J. Biol. Chem. 268, 2416-2424. 
Sebastiao, P., Dauter, Z., Saraiva, M.J. and Damas, A.M. (1996) 
Acta Crystallogr. D52, 566-568. 
Andrews, P. (1964) Biochem. J. 91, 222-223. 
Brito, R.M.M., Reddick, R., Bennett, G.N., Rudolph, F.B. and 
Rosevear, P.R. (1990) Biochemistry 29, 9825-9831. 
Furuya, H., Saraiva, M.J.M., Gawinowicz, M.A., Alves, I.L., 
Costa, P.P., Sasaki, H., Goto, I. and Sakaki, Y. (1991) Biochem-
istry 30, 2415-2421. 
Almeida, M.R., Damas, A.M., Lans, M.C., Brouwer, A. and 
Saraiva, M.J.M. (1997) Endocrine 6, 309-315. 
Van Jaarsveld, P.P., Edelhoch, H., Goodman, D.S. and Robbins, 
J. (1973) J. Biol. Chem. 548, 4698^1705. 
Alves, I.L., Hays, M.T. and Saraiva, M.J.M. (1997) Eur. J. Bio-
chem. (in press). 
